Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.07. | Acarix AB: Acarix Enters MENA Region with First Major Order, Expanding Global Presence | 165 | GlobeNewswire (Europe) | Malmö, Sweden - July 8, 2025 - Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order in the Middle East and North Africa (MENA) region.... ► Artikel lesen | |
26.06. | Acarix AB: Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor System in U.S. Emergency Departments | 137 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor®... ► Artikel lesen | |
16.06. | Acarix AB: Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD | 154 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at... ► Artikel lesen | |
12.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2025 | 199 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The report highlights continued growth in the U.S.... ► Artikel lesen | |
13.02. | Acarix Publishes Year-End Report 2024 - Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts | 270 | PR Newswire | OKLAHOMA CITY, Feb. 13, 2025 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues... ► Artikel lesen | |
07.11.24 | Acarix AB: Acarix Publishes Third Quarter 2024 Report | 170 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the third quarter of 2024. The company has made significant progress toward operational... ► Artikel lesen | |
ACARIX Aktie jetzt für 0€ handeln | |||||
22.08.24 | Acarix AB (publ) publishes Interim Report, April - June 2024 | 260 | PR Newswire | NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its financial results for the second quarter of 2024. The company achieved... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS MEDICAL CARE | 45,010 | -1,70 % | Fresenius Medical Care-Aktie: Dunkle Vorzeichen! | Die Fresenius Medical Care-Aktie steht am Montag unter Druck und das nicht ohne Grund. Das belastet den DAX-Konzern jetzt, und darum könnte hier ein Verkauf aktuell die beste Option sein. Unter Druck... ► Artikel lesen | |
CARL ZEISS MEDITEC | 51,05 | -0,39 % | Carl Zeiss Meditec Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
ECKERT & ZIEGLER | 64,95 | +0,70 % | Eckert&Ziegler Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
UNITEDHEALTH | 238,85 | -0,21 % | Kriminelle Machenschaften: UnitedHealth: Nun also doch! | © Foto: UnsplashIm Mai hatte der US-Krankenversicherer UnitedHealth noch dementiert, dass das US-Ministerium gegen das Unternehmen ermitteln würde, nun ist es doch so. US-Krankenversicherer in der Krise... ► Artikel lesen | |
HIMS & HERS HEALTH | 49,340 | +0,53 % | Hims & Hers drops as U.S. lawmakers target copycat weight loss drugs | ||
BICO GROUP | 3,646 | -0,05 % | Schock-News für Bico Group Anleger vor dem Wochenende: So müssen Sie heute noch auf diese Sondermeldung reagieren! | ||
NUGEN MEDICAL DEVICES | 0,035 | -4,35 % | Beaking News: Vive la InsuJet - mit der Krankenkasse zum Erfolg? | ||
SPINEWAY | 0,110 | -3,51 % | Spineway: GMED approval for new production line dedicated to ESP prostheses - First production of LP-ESP intervertebral disc prostheses | Press release Ecully, July 3, 2025 - 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | 'We want to be different than pharma': Evofem CEO on the TikTok that tripled interest in Phexxi birth control | ||
UNIDOC HEALTH | 0,142 | -2,21 % | UniDoc Health Corp. kündigt Teilnahme an der Ukraine Recovery Conference (URC2025) an | - UniDoc wird auf der internationalen Veranstaltung in Rom (Italien) seine laufenden humanitären und innovativen Bemühungen im Gesundheitswesen
präsentieren
VANCOUVER,... ► Artikel lesen | |
VERU | 0,491 | +2,46 % | VERU INC. - 8-K, Current Report | ||
CLARIANE | 4,990 | +0,20 % | Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network | Press release June 12th, 2025 Clariane completes its plan to strengthen its financial structure with the disposal of its Petits-fils home care services network Paris, June 12th, 2025 - Clariane (CLARI.PA... ► Artikel lesen | |
SENSEONICS | 0,480 | +1,59 % | Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to approximately... ► Artikel lesen | |
BONESUPPORT | 28,940 | -0,14 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q2 2025 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the second quarter 2025.
CONTINUED STRONG GROWTH IN THE... ► Artikel lesen | |
VIROMED MEDICAL | 3,480 | -9,84 % | EQS-News: Viromed Medical AG vereinbart Vertriebskooperation mit TriPart für die Markteinführung von ViroCAP® und PulmoPlas® in der Türkei | EQS-News: Viromed Medical AG
/ Schlagwort(e): Kooperation
Viromed Medical AG vereinbart Vertriebskooperation mit TriPart für die Markteinführung von ViroCAP® und PulmoPlas® in... ► Artikel lesen |